by Elizabeth Kissling | Feb 9, 2010 | Advertising, Birth Control, Law/Legal, Pharmaceutical
Guest Post from Evil Slutopia There are Tupperware parties, Passion Parties, Pampered Chef parties, and…Mirena IUD parties? Yes, apparently these events popped up early last year and were a joint effort from Bayer Pharmaceuticals and the mom marketing site Mom...
by Elizabeth Kissling | Feb 7, 2010 | Menopause, New Research, Pharmaceutical
A study to be published in the British Medical Journal’s Thorax,* which focuses on respiratory medicine, finds that estrogen-only hormone treatment for menopause symptoms is associated with higher risk of asthma. The study involved nearly 58,000 women over 12...
by Elizabeth Kissling | Jan 20, 2010 | Dysmenorrhea, Menstruation, New Research, Pharmaceutical
A new meta-analysis of previous research on acetaminophen (also known as paracetamol outside the U.S.) vs. NSAIDs (nonsteroidal anti-inflammatory drugs) for treatment of menstrual pain indicates that NSAIDs are more effective. NSAIDs include aspirin, ibuprofen, and...
by Elizabeth Kissling | Jan 8, 2010 | Advertising, Birth Control
SMCR and re:Cycling‘s own Chris Hitchcock is featured in a menstrual suppression for-and-against article at MSN today. Chris explains why using hormonal contraceptives to stop periods is generally bad idea, except in very limited medical circumstances. Leslie...
by Elizabeth Kissling | Dec 27, 2009 | Birth Control, New Research, Pharmaceutical
New research from the University of Texas Medical Branch at Galveston finds that nearly half of women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, will experience high bone mineral density (BMD) loss in the hip or lower...
